Autnet的个人主页 - 老虎社区

Autnet

Autnet

暂无个人介绍

IP属地：未知

8关注

1粉丝

0主题

0勋章

2021-12-07

Quite relieved to hear this piece of news. Let’s continue to do our part and heal the world☘️☘️☘️

Vaccine Stocks: Why MRNA, BNTX, NVAX, PFE Stocks Are Stumbling Today

2021-12-02

Heal the world…. Make it a better place😊

抱歉，原内容已删除

2021-12-14

Heal the world… make it a better place…. For you and for me☘️☘️☘️ Merry Christmas to All🎄🎄🎄

Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%

2021-12-04

Heal the world…make it a better place☘️☘️☘️

抱歉，原内容已删除

2021-11-23

Hmmm… both

抱歉，原内容已删除

2021-12-08

Thanks for the advice. Will seriously consider if selling is imminent… or later?

Apple Stock: What Happens When The Cash Runs Out?

2021-12-01

Let’s pray that vaccines available still continue to work on all variants…

Is a Stock Market Correction Coming? Here’s a Big Red Flag

2021-11-24

Bought some for long terms gain… 😄

抱歉，原内容已删除

2021-11-09

$Lucid Group Inc(LCID)$Up up all the way 😄

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"4098678914535810","uuid":"4098678914535810","gmtCreate":1635575848318,"gmtModify":1636431495881,"name":"Autnet","pinyin":"autnet","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/bda7244c323527b36de06db53911ab08","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":8,"tweetSize":9,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.11.04","exceedPercentage":"80.58%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":3,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":11,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"hot","tweets":[{"id":604441479,"gmtCreate":1639441708814,"gmtModify":1639441708882,"author":{"id":"4098678914535810","authorId":"4098678914535810","name":"Autnet","avatar":"https://static.tigerbbs.com/bda7244c323527b36de06db53911ab08","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098678914535810","authorIdStr":"4098678914535810"},"themes":[],"htmlText":"Heal the world… make it a better place…. For you and for me☘️☘️☘️ Merry Christmas to All🎄🎄🎄","listText":"Heal the world… make it a better place…. For you and for me☘️☘️☘️ Merry Christmas to All🎄🎄🎄","text":"Heal the world… make it a better place…. For you and for me☘️☘️☘️ Merry Christmas to All🎄🎄🎄","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/604441479","repostId":"1133455327","repostType":4,"repost":{"id":"1133455327","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639406792,"share":"https://www.laohu8.com/m/news/1133455327?lang=&edition=full","pubTime":"2021-12-13 22:46","market":"us","language":"en","title":"Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1133455327","media":"Tiger Newspress","summary":"Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping ove","content":"<p>Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%.</p>\n<p><img src=\"https://static.tigerbbs.com/67d7d63c674aea0dff679d8317fc7728\" tg-width=\"537\" tg-height=\"199\" referrerpolicy=\"no-referrer\">A new Israeli study&nbsp;showed that a booster shot from their Covid-19 vaccine provided strong protection against severe illness from the omicron variant.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-13 22:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%.</p>\n<p><img src=\"https://static.tigerbbs.com/67d7d63c674aea0dff679d8317fc7728\" tg-width=\"537\" tg-height=\"199\" referrerpolicy=\"no-referrer\">A new Israeli study&nbsp;showed that a booster shot from their Covid-19 vaccine provided strong protection against severe illness from the omicron variant.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","BNTX":"BioNTech SE"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1133455327","content_text":"Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%.\nA new Israeli study showed that a booster shot from their Covid-19 vaccine provided strong protection against severe illness from the omicron variant.","news_type":1,"symbols_score_info":{"BNTX":0.9,"NVAX":0.9}},"isVote":1,"tweetType":1,"viewCount":1315,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602030171,"gmtCreate":1638937159242,"gmtModify":1638937159242,"author":{"id":"4098678914535810","authorId":"4098678914535810","name":"Autnet","avatar":"https://static.tigerbbs.com/bda7244c323527b36de06db53911ab08","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098678914535810","authorIdStr":"4098678914535810"},"themes":[],"htmlText":"Thanks for the advice. Will seriously consider if selling is imminent… or later?","listText":"Thanks for the advice. Will seriously consider if selling is imminent… or later?","text":"Thanks for the advice. Will seriously consider if selling is imminent… or later?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602030171","repostId":"1105817084","repostType":4,"repost":{"id":"1105817084","kind":"news","pubTimestamp":1638933976,"share":"https://www.laohu8.com/m/news/1105817084?lang=&edition=full","pubTime":"2021-12-08 11:26","market":"us","language":"en","title":"Apple Stock: What Happens When The Cash Runs Out?","url":"https://stock-news.laohu8.com/highlight/detail?id=1105817084","media":"TheStreet","summary":"Apple is about to run out of cash. This statement may sound lucrac is to most Apple stock  investors, since the Cupertino company has been a cash-generating machine in the past many years. But even the management team knows this to be true.Today, the Apple Maven talks about what has been happening to the iPhone maker’s once giant pile of cash, and what the declining balances may mean for shareholders.To be fair, “running out of cash” in this context does not mean that Apple’s checking accounts a","content":"<p>Apple is about to run out of cash. This statement may sound lucrac&nbsp;is to most Apple stock&nbsp;(<b>AAPL</b>)&nbsp;investors, since the Cupertino company has been a cash-generating machine in the past many years. But even the management team&nbsp;knows&nbsp;this to be true.</p>\n<p>Today, the Apple Maven talks about what has been happening to the iPhone maker’s once giant pile of cash, and what the declining balances may mean for shareholders.</p>\n<p><b>Apple heading to net cash neutral</b></p>\n<p>To be fair, “running out of cash” in this context does not mean that Apple’s checking accounts at the bank will dry out. It simply means that the company’s debt balances will roughly offset its cash position — i.e. Apple will become net cash neutral.</p>\n<p>The chart below shows the evolution of Apple’s gross cash (blue bars) and net cash (orange bars) balances since 2011. Ten years ago was when then-CEO Steve Jobs stepped down and turned the control of the company over to then-COO Tim Cook.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/435c5199979bc64d49899feed29d15fb\" tg-width=\"1200\" tg-height=\"723\" width=\"100%\" height=\"auto\"><span>Figure 2:Apple's cash position, fiscal 2012-2021.data from Seeking Alpha</span></p>\n<p>Starting in 2012, Apple began issuing debt for the first time in its history. By 2017, the company boasted the largest gross and net-of-debt cash balances that it had ever seen in its books. But since then, both numbers have been dwindling. This year’s $72 billion in net cash is less than half the amount of about four years ago.</p>\n<p><b>What happens when cash runs out?</b></p>\n<p>The chart below shows that, prior to Tim Cook as CEO, Apple was very timid at deploying its cash reserves. While capex and dividend payments increased quickly (large M&amp;A has never been a thing for Apple), buybacks skyrocketed. Apple has spent more than three times as much in share repurchases since 2018 than it did in capex and dividends combined.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/e0ecee1dedf8551b616732dc7180c574\" tg-width=\"1200\" tg-height=\"694\" width=\"100%\" height=\"auto\"><span>Figure 3:Apple's cash deployment by major category.data from Seeking Alpha</span></p>\n<p>As Apple’s cash balance continues to dip, it is reasonable to expect the pace of share retirement to decline as well. This is true not only because of a leaner balance sheet, but because AAPL stock trades at a much richer price today — thus, it costs Apple more to buy back each share of its own equity.</p>\n<p>Why is this relevant for investors? Over the past decade, Apple’s shares outstanding have declined by 10 billion units to 16.7 billion. Share count is the denominator in EPS (earnings per share) and EPS is the denominator in price-to-earnings. Therefore, buybacks alone have probably been responsible for a good chunk of Apple stock’s climb in the past several years.</p>\n<p>At the current stock price of $165 apiece, Apple can afford to retire around 435 million more shares with its current net cash balance, or barely 3% of the float. After that point, the Cupertino company might need to scale back on repurchases or borrow in order to keep buying its stock.</p>\n<p><b>Should investors worry?</b></p>\n<p>I think that Apple stock could suffer, at least from deteriorated investor sentiment, if or once it begins to slow down the pace of its share buyback efforts. However, I also believe that this is only one aspect of the investment thesis that people should consider.</p>\n<p>I remain optimistic about Apple stock from a business fundamentals perspective. The Cupertino company seems to have found the sweet spot in demand for its products and services, which I believe bodes very well for AAPL in the foreseeable future.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple Stock: What Happens When The Cash Runs Out?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple Stock: What Happens When The Cash Runs Out?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-08 11:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/apple/stock/apple-stock-what-happens-when-the-cash-runs-out><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Apple is about to run out of cash. This statement may sound lucrac is to most Apple stock (AAPL) investors, since the Cupertino company has been a cash-generating machine in the past many years. But ...</p>\n\n<a href=\"https://www.thestreet.com/apple/stock/apple-stock-what-happens-when-the-cash-runs-out\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.thestreet.com/apple/stock/apple-stock-what-happens-when-the-cash-runs-out","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1105817084","content_text":"Apple is about to run out of cash. This statement may sound lucrac is to most Apple stock (AAPL) investors, since the Cupertino company has been a cash-generating machine in the past many years. But even the management team knows this to be true.\nToday, the Apple Maven talks about what has been happening to the iPhone maker’s once giant pile of cash, and what the declining balances may mean for shareholders.\nApple heading to net cash neutral\nTo be fair, “running out of cash” in this context does not mean that Apple’s checking accounts at the bank will dry out. It simply means that the company’s debt balances will roughly offset its cash position — i.e. Apple will become net cash neutral.\nThe chart below shows the evolution of Apple’s gross cash (blue bars) and net cash (orange bars) balances since 2011. Ten years ago was when then-CEO Steve Jobs stepped down and turned the control of the company over to then-COO Tim Cook.\nFigure 2:Apple's cash position, fiscal 2012-2021.data from Seeking Alpha\nStarting in 2012, Apple began issuing debt for the first time in its history. By 2017, the company boasted the largest gross and net-of-debt cash balances that it had ever seen in its books. But since then, both numbers have been dwindling. This year’s $72 billion in net cash is less than half the amount of about four years ago.\nWhat happens when cash runs out?\nThe chart below shows that, prior to Tim Cook as CEO, Apple was very timid at deploying its cash reserves. While capex and dividend payments increased quickly (large M&A has never been a thing for Apple), buybacks skyrocketed. Apple has spent more than three times as much in share repurchases since 2018 than it did in capex and dividends combined.\nFigure 3:Apple's cash deployment by major category.data from Seeking Alpha\nAs Apple’s cash balance continues to dip, it is reasonable to expect the pace of share retirement to decline as well. This is true not only because of a leaner balance sheet, but because AAPL stock trades at a much richer price today — thus, it costs Apple more to buy back each share of its own equity.\nWhy is this relevant for investors? Over the past decade, Apple’s shares outstanding have declined by 10 billion units to 16.7 billion. Share count is the denominator in EPS (earnings per share) and EPS is the denominator in price-to-earnings. Therefore, buybacks alone have probably been responsible for a good chunk of Apple stock’s climb in the past several years.\nAt the current stock price of $165 apiece, Apple can afford to retire around 435 million more shares with its current net cash balance, or barely 3% of the float. After that point, the Cupertino company might need to scale back on repurchases or borrow in order to keep buying its stock.\nShould investors worry?\nI think that Apple stock could suffer, at least from deteriorated investor sentiment, if or once it begins to slow down the pace of its share buyback efforts. However, I also believe that this is only one aspect of the investment thesis that people should consider.\nI remain optimistic about Apple stock from a business fundamentals perspective. The Cupertino company seems to have found the sweet spot in demand for its products and services, which I believe bodes very well for AAPL in the foreseeable future.","news_type":1,"symbols_score_info":{"AAPL":0.9}},"isVote":1,"tweetType":1,"viewCount":1737,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606181174,"gmtCreate":1638842955281,"gmtModify":1638842955385,"author":{"id":"4098678914535810","authorId":"4098678914535810","name":"Autnet","avatar":"https://static.tigerbbs.com/bda7244c323527b36de06db53911ab08","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098678914535810","authorIdStr":"4098678914535810"},"themes":[],"htmlText":"Quite relieved to hear this piece of news. Let’s continue to do our part and heal the world☘️☘️☘️","listText":"Quite relieved to hear this piece of news. Let’s continue to do our part and heal the world☘️☘️☘️","text":"Quite relieved to hear this piece of news. Let’s continue to do our part and heal the world☘️☘️☘️","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/606181174","repostId":"1165217690","repostType":2,"repost":{"id":"1165217690","kind":"news","pubTimestamp":1638841605,"share":"https://www.laohu8.com/m/news/1165217690?lang=&edition=full","pubTime":"2021-12-07 09:46","market":"us","language":"en","title":"Vaccine Stocks: Why MRNA, BNTX, NVAX, PFE Stocks Are Stumbling Today","url":"https://stock-news.laohu8.com/highlight/detail?id=1165217690","media":"InvestorPlace","summary":"Good news for public health can sometimes mean bad news for vaccine stocks. Today reminded us exactl","content":"<p>Good news for public health can sometimes mean bad news for vaccine stocks. Today reminded us exactly why. After more than a week of ominous reports on the omicron virus and mounting speculation about its severity, yesterday brought some welcome news. Dr. Anthony Fauci, White House chief medical officer and a trusted expert on the virus, stated yesterday that some clear preliminary data was finally starting to emerge on the severity of the new variant and that so far, the results looked“encouraging.”</p>\n<p>What’s Happening With Vaccine Stocks</p>\n<p>Since news of the new variant first began dominating media airwaves, vaccine producers have been scrambling to be the first to address the new Covid-19 strain that threatened to undo the work that sent their stocks up earlier this year. Today has seen all the prominent names among vaccine stocks plunge across the board. While this isn’t strictly due to Dr. Fauci’s comments, it’s possible that the demand for new vaccine innovations and treatments may not be as great as we feared only a few days ago.</p>\n<p><b>BioNTech</b>&nbsp;(NASDAQ:<b><u>BNTX</u></b>) has suffered the worst declines of the day among vaccine stocks, with shares down almost 19% as of this writing. Next in line is&nbsp;<b>Moderna</b>(NASDAQ:<b><u>MRNA</u></b>), which has fallen more than 13%. Then,&nbsp;<b>Novavax’s</b>(NASDAQ:<b><u>NVAX</u></b>)declines come in just shy of 12%. Rounding out the pack is&nbsp;<b>Pfizer</b>(NYSE:<b><u>PFE</u></b>), which is in the red by just over 5% as trading winds to a close today.</p>\n<p>Why It Matters</p>\n<p>The clearest indication we should take from today’s events is that market mentality is shifting. This is evidenced by the performances we’ve seen not just from vaccine stocks but from other sectors that were differently affected by the spreading variant news. As&nbsp;<i>InvestorPlace’</i>s Shrey Dua reports,&nbsp;cruise ship stocks&nbsp;such as&nbsp;<b>Royal Caribbean</b>(NYSE:<b><u>RCL</u></b>) and&nbsp;<b>Carnival</b>(NYSE:<b><u>CCL</u></b>) are back in the green today after a troubling week of variant concerns. The same can be said for airline stocks, as names such as&nbsp;<b>Delta</b>&nbsp;(NYSE:<b><u>DAL</u></b>) and&nbsp;<b>Southwest</b>&nbsp;(NYSE:<b><u>LUV</u></b>) have gained some altitude today.</p>\n<p>Of course, it’s too soon to tell what the future will look like. The preliminary results upon which Dr. Fauci commented are exactly that — preliminary. Scientists and medical researchers still have plenty of research to do before they will be able outline a bigger picture. Dr. Fauci was careful to add that while there does not seem to be a “great degree of severity” to the spreading variant, it is still too early for any definitive conclusions to be reached. Omicron is still very much a variant of concern.</p>\n<p>What It Means</p>\n<p>Even if the variant does not end up posing as serious a threat to highly vaccinated countries as has been speculated, the need for vaccines isn’t going to go away. Fear of the variant has spiked&nbsp;demand&nbsp;for vaccinations in the U.S., and many countries are still struggling to get more of their populations partially or fully vaccinated. The industry landscape may not end up looking quite as bleak close to home as some of us have feared. However, that doesn’t mean that the demand for vaccines won’t be increasing throughout the months ahead.</p>\n<p>This news certainly doesn’t mean that a bearish play on vaccine stocks is advisable. Far from it, in fact. Novavax has an&nbsp;important catalyst&nbsp;rapidly approaching as the World Health Organization (WHO) considers granting it emergency use authorization. More than likely, vaccine stocks will be quick to rebound.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaccine Stocks: Why MRNA, BNTX, NVAX, PFE Stocks Are Stumbling Today</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaccine Stocks: Why MRNA, BNTX, NVAX, PFE Stocks Are Stumbling Today\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-07 09:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/12/vaccine-stocks-why-mrna-bntx-nvax-pfe-stocks-are-stumbling-today/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Good news for public health can sometimes mean bad news for vaccine stocks. Today reminded us exactly why. After more than a week of ominous reports on the omicron virus and mounting speculation about...</p>\n\n<a href=\"https://investorplace.com/2021/12/vaccine-stocks-why-mrna-bntx-nvax-pfe-stocks-are-stumbling-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","MRNA":"Moderna, Inc.","BNTX":"BioNTech SE","PFE":"辉瑞"},"source_url":"https://investorplace.com/2021/12/vaccine-stocks-why-mrna-bntx-nvax-pfe-stocks-are-stumbling-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1165217690","content_text":"Good news for public health can sometimes mean bad news for vaccine stocks. Today reminded us exactly why. After more than a week of ominous reports on the omicron virus and mounting speculation about its severity, yesterday brought some welcome news. Dr. Anthony Fauci, White House chief medical officer and a trusted expert on the virus, stated yesterday that some clear preliminary data was finally starting to emerge on the severity of the new variant and that so far, the results looked“encouraging.”\nWhat’s Happening With Vaccine Stocks\nSince news of the new variant first began dominating media airwaves, vaccine producers have been scrambling to be the first to address the new Covid-19 strain that threatened to undo the work that sent their stocks up earlier this year. Today has seen all the prominent names among vaccine stocks plunge across the board. While this isn’t strictly due to Dr. Fauci’s comments, it’s possible that the demand for new vaccine innovations and treatments may not be as great as we feared only a few days ago.\nBioNTech (NASDAQ:BNTX) has suffered the worst declines of the day among vaccine stocks, with shares down almost 19% as of this writing. Next in line is Moderna(NASDAQ:MRNA), which has fallen more than 13%. Then, Novavax’s(NASDAQ:NVAX)declines come in just shy of 12%. Rounding out the pack is Pfizer(NYSE:PFE), which is in the red by just over 5% as trading winds to a close today.\nWhy It Matters\nThe clearest indication we should take from today’s events is that market mentality is shifting. This is evidenced by the performances we’ve seen not just from vaccine stocks but from other sectors that were differently affected by the spreading variant news. As InvestorPlace’s Shrey Dua reports, cruise ship stocks such as Royal Caribbean(NYSE:RCL) and Carnival(NYSE:CCL) are back in the green today after a troubling week of variant concerns. The same can be said for airline stocks, as names such as Delta (NYSE:DAL) and Southwest (NYSE:LUV) have gained some altitude today.\nOf course, it’s too soon to tell what the future will look like. The preliminary results upon which Dr. Fauci commented are exactly that — preliminary. Scientists and medical researchers still have plenty of research to do before they will be able outline a bigger picture. Dr. Fauci was careful to add that while there does not seem to be a “great degree of severity” to the spreading variant, it is still too early for any definitive conclusions to be reached. Omicron is still very much a variant of concern.\nWhat It Means\nEven if the variant does not end up posing as serious a threat to highly vaccinated countries as has been speculated, the need for vaccines isn’t going to go away. Fear of the variant has spiked demand for vaccinations in the U.S., and many countries are still struggling to get more of their populations partially or fully vaccinated. The industry landscape may not end up looking quite as bleak close to home as some of us have feared. However, that doesn’t mean that the demand for vaccines won’t be increasing throughout the months ahead.\nThis news certainly doesn’t mean that a bearish play on vaccine stocks is advisable. Far from it, in fact. Novavax has an important catalyst rapidly approaching as the World Health Organization (WHO) considers granting it emergency use authorization. More than likely, vaccine stocks will be quick to rebound.","news_type":1,"symbols_score_info":{"BNTX":0.9,"MRNA":0.9,"NVAX":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":1938,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608007502,"gmtCreate":1638578434765,"gmtModify":1638578434765,"author":{"id":"4098678914535810","authorId":"4098678914535810","name":"Autnet","avatar":"https://static.tigerbbs.com/bda7244c323527b36de06db53911ab08","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098678914535810","authorIdStr":"4098678914535810"},"themes":[],"htmlText":"Heal the world…make it a better place☘️☘️☘️","listText":"Heal the world…make it a better place☘️☘️☘️","text":"Heal the world…make it a better place☘️☘️☘️","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/608007502","repostId":"1177965649","repostType":2,"isVote":1,"tweetType":1,"viewCount":2620,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603626872,"gmtCreate":1638407150732,"gmtModify":1638407150803,"author":{"id":"4098678914535810","authorId":"4098678914535810","name":"Autnet","avatar":"https://static.tigerbbs.com/bda7244c323527b36de06db53911ab08","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098678914535810","authorIdStr":"4098678914535810"},"themes":[],"htmlText":"Heal the world…. Make it a better place😊","listText":"Heal the world…. Make it a better place😊","text":"Heal the world…. Make it a better place😊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/603626872","repostId":"1196358645","repostType":4,"isVote":1,"tweetType":1,"viewCount":2489,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609779087,"gmtCreate":1638332392917,"gmtModify":1638332392917,"author":{"id":"4098678914535810","authorId":"4098678914535810","name":"Autnet","avatar":"https://static.tigerbbs.com/bda7244c323527b36de06db53911ab08","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098678914535810","authorIdStr":"4098678914535810"},"themes":[],"htmlText":"Let’s pray that vaccines available still continue to work on all variants…","listText":"Let’s pray that vaccines available still continue to work on all variants…","text":"Let’s pray that vaccines available still continue to work on all variants…","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/609779087","repostId":"1134775339","repostType":2,"repost":{"id":"1134775339","kind":"news","pubTimestamp":1638325598,"share":"https://www.laohu8.com/m/news/1134775339?lang=&edition=full","pubTime":"2021-12-01 10:26","market":"us","language":"en","title":"Is a Stock Market Correction Coming? Here’s a Big Red Flag","url":"https://stock-news.laohu8.com/highlight/detail?id=1134775339","media":"Barrons","summary":"To say that the Omicron variant is shaking the market would be an understatement. But add that stock","content":"<p>To say that the Omicron variant is shaking the market would be an understatement. But add that stocks are more expensive than they’ve ever been—and a true correction now wouldn’t surprise anybody.</p>\n<p>The S&amp;P 500 has fallen almost 3% from its all-time high hit in late November, just before scientists in South Africa reported the new Covid-19 strain. On Friday, the market had its worst day of the year. Tuesday was more ugliness—producers of vaccines and treatments predicted their remedies probably wouldn’t be as effective against Omicron as other variants.</p>\n<p>But that true correction—a 10% drop—has been elusive, even during all these months of the pandemic. And that itself is a bit astonishing, since corrections are often a normal part of a larger bull market.</p>\n<p>One indicator, though, forecasts a correction—like a dark cloud usually brings rain. The total U.S. equity market capitalization is about 215% of U.S. gross domestic product—the highest level ever, according to Global Financial Data.</p>\n<p>Such a high number isn’t good. It’s bad, often a sign that a correction is just around the corner</p>\n<p>In 1929, market cap to GDP hit an all-time high of about 100%, just before the famous stock market crash late that year. In 2000, another high at about 150%, just before a bear market—a drop of at least 20%—began. In 2008, a multiyear high, just ahead of the financial crisis.</p>\n<p>The upshot: Maybe a correction; then again, maybe not. It’s all in the hands of investors.</p>\n<p>To be sure, stock valuations aren’t known to be the best timing tool for investors deciding if they should do more buying or selling. Valuations can stay high for a long time.</p>\n<p>For most of the pandemic era, in fact, the market has been valued at its highest level relative to GDP ever. But high valuations do indicate that when—and if—the economic outlook really does deteriorate, stocks can fall really hard.</p>\n<p>“There is certainly the potential for additional market drops and heightened volatility in coming weeks as a result of this variant, especially given all the uncertainty surrounding it,” wrote Kristina Hooper, chief global market strategist at Invesco. “There is room for a decent correction.”</p>\n<p>What the market needs now is a little hope—that vaccines will be effective against the new variant. Otherwise, get ready for a correction.</p>","source":"market_watch","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is a Stock Market Correction Coming? Here’s a Big Red Flag</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs a Stock Market Correction Coming? Here’s a Big Red Flag\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-01 10:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/articles/stock-market-correction-51638305804?mod=newsviewer_click_seemore><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>To say that the Omicron variant is shaking the market would be an understatement. But add that stocks are more expensive than they’ve ever been—and a true correction now wouldn’t surprise anybody.\nThe...</p>\n\n<a href=\"https://www.marketwatch.com/articles/stock-market-correction-51638305804?mod=newsviewer_click_seemore\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index"},"source_url":"https://www.marketwatch.com/articles/stock-market-correction-51638305804?mod=newsviewer_click_seemore","is_english":true,"share_image_url":"https://static.laohu8.com/599a65733b8245fcf7868668ef9ad712","article_id":"1134775339","content_text":"To say that the Omicron variant is shaking the market would be an understatement. But add that stocks are more expensive than they’ve ever been—and a true correction now wouldn’t surprise anybody.\nThe S&P 500 has fallen almost 3% from its all-time high hit in late November, just before scientists in South Africa reported the new Covid-19 strain. On Friday, the market had its worst day of the year. Tuesday was more ugliness—producers of vaccines and treatments predicted their remedies probably wouldn’t be as effective against Omicron as other variants.\nBut that true correction—a 10% drop—has been elusive, even during all these months of the pandemic. And that itself is a bit astonishing, since corrections are often a normal part of a larger bull market.\nOne indicator, though, forecasts a correction—like a dark cloud usually brings rain. The total U.S. equity market capitalization is about 215% of U.S. gross domestic product—the highest level ever, according to Global Financial Data.\nSuch a high number isn’t good. It’s bad, often a sign that a correction is just around the corner\nIn 1929, market cap to GDP hit an all-time high of about 100%, just before the famous stock market crash late that year. In 2000, another high at about 150%, just before a bear market—a drop of at least 20%—began. In 2008, a multiyear high, just ahead of the financial crisis.\nThe upshot: Maybe a correction; then again, maybe not. It’s all in the hands of investors.\nTo be sure, stock valuations aren’t known to be the best timing tool for investors deciding if they should do more buying or selling. Valuations can stay high for a long time.\nFor most of the pandemic era, in fact, the market has been valued at its highest level relative to GDP ever. But high valuations do indicate that when—and if—the economic outlook really does deteriorate, stocks can fall really hard.\n“There is certainly the potential for additional market drops and heightened volatility in coming weeks as a result of this variant, especially given all the uncertainty surrounding it,” wrote Kristina Hooper, chief global market strategist at Invesco. “There is room for a decent correction.”\nWhat the market needs now is a little hope—that vaccines will be effective against the new variant. Otherwise, get ready for a correction.","news_type":1,"symbols_score_info":{".SPX":0.9}},"isVote":1,"tweetType":1,"viewCount":2214,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":874183713,"gmtCreate":1637743910331,"gmtModify":1637743910331,"author":{"id":"4098678914535810","authorId":"4098678914535810","name":"Autnet","avatar":"https://static.tigerbbs.com/bda7244c323527b36de06db53911ab08","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098678914535810","authorIdStr":"4098678914535810"},"themes":[],"htmlText":"Bought some for long terms gain… 😄","listText":"Bought some for long terms gain… 😄","text":"Bought some for long terms gain… 😄","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/874183713","repostId":"2185804343","repostType":2,"isVote":1,"tweetType":1,"viewCount":2167,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875628055,"gmtCreate":1637646197373,"gmtModify":1637646200152,"author":{"id":"4098678914535810","authorId":"4098678914535810","name":"Autnet","avatar":"https://static.tigerbbs.com/bda7244c323527b36de06db53911ab08","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098678914535810","authorIdStr":"4098678914535810"},"themes":[],"htmlText":"Hmmm… both","listText":"Hmmm… both","text":"Hmmm… both","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/875628055","repostId":"1107351089","repostType":4,"isVote":1,"tweetType":1,"viewCount":1834,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":844218737,"gmtCreate":1636429829281,"gmtModify":1636430056505,"author":{"id":"4098678914535810","authorId":"4098678914535810","name":"Autnet","avatar":"https://static.tigerbbs.com/bda7244c323527b36de06db53911ab08","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098678914535810","authorIdStr":"4098678914535810"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LCID\">$Lucid Group Inc(LCID)$</a>Up up all the way 😄","listText":"<a href=\"https://laohu8.com/S/LCID\">$Lucid Group Inc(LCID)$</a>Up up all the way 😄","text":"$Lucid Group Inc(LCID)$Up up all the way 😄","images":[{"img":"https://static.tigerbbs.com/6d051f1bdcdd23ae132420f6f7bf3c8d","width":"1125","height":"2710"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/844218737","isVote":1,"tweetType":1,"viewCount":2612,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0}],"hots":[{"id":606181174,"gmtCreate":1638842955281,"gmtModify":1638842955385,"author":{"id":"4098678914535810","authorId":"4098678914535810","name":"Autnet","avatar":"https://static.tigerbbs.com/bda7244c323527b36de06db53911ab08","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098678914535810","authorIdStr":"4098678914535810"},"themes":[],"htmlText":"Quite relieved to hear this piece of news. Let’s continue to do our part and heal the world☘️☘️☘️","listText":"Quite relieved to hear this piece of news. Let’s continue to do our part and heal the world☘️☘️☘️","text":"Quite relieved to hear this piece of news. Let’s continue to do our part and heal the world☘️☘️☘️","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/606181174","repostId":"1165217690","repostType":2,"repost":{"id":"1165217690","kind":"news","pubTimestamp":1638841605,"share":"https://www.laohu8.com/m/news/1165217690?lang=&edition=full","pubTime":"2021-12-07 09:46","market":"us","language":"en","title":"Vaccine Stocks: Why MRNA, BNTX, NVAX, PFE Stocks Are Stumbling Today","url":"https://stock-news.laohu8.com/highlight/detail?id=1165217690","media":"InvestorPlace","summary":"Good news for public health can sometimes mean bad news for vaccine stocks. Today reminded us exactl","content":"<p>Good news for public health can sometimes mean bad news for vaccine stocks. Today reminded us exactly why. After more than a week of ominous reports on the omicron virus and mounting speculation about its severity, yesterday brought some welcome news. Dr. Anthony Fauci, White House chief medical officer and a trusted expert on the virus, stated yesterday that some clear preliminary data was finally starting to emerge on the severity of the new variant and that so far, the results looked“encouraging.”</p>\n<p>What’s Happening With Vaccine Stocks</p>\n<p>Since news of the new variant first began dominating media airwaves, vaccine producers have been scrambling to be the first to address the new Covid-19 strain that threatened to undo the work that sent their stocks up earlier this year. Today has seen all the prominent names among vaccine stocks plunge across the board. While this isn’t strictly due to Dr. Fauci’s comments, it’s possible that the demand for new vaccine innovations and treatments may not be as great as we feared only a few days ago.</p>\n<p><b>BioNTech</b>&nbsp;(NASDAQ:<b><u>BNTX</u></b>) has suffered the worst declines of the day among vaccine stocks, with shares down almost 19% as of this writing. Next in line is&nbsp;<b>Moderna</b>(NASDAQ:<b><u>MRNA</u></b>), which has fallen more than 13%. Then,&nbsp;<b>Novavax’s</b>(NASDAQ:<b><u>NVAX</u></b>)declines come in just shy of 12%. Rounding out the pack is&nbsp;<b>Pfizer</b>(NYSE:<b><u>PFE</u></b>), which is in the red by just over 5% as trading winds to a close today.</p>\n<p>Why It Matters</p>\n<p>The clearest indication we should take from today’s events is that market mentality is shifting. This is evidenced by the performances we’ve seen not just from vaccine stocks but from other sectors that were differently affected by the spreading variant news. As&nbsp;<i>InvestorPlace’</i>s Shrey Dua reports,&nbsp;cruise ship stocks&nbsp;such as&nbsp;<b>Royal Caribbean</b>(NYSE:<b><u>RCL</u></b>) and&nbsp;<b>Carnival</b>(NYSE:<b><u>CCL</u></b>) are back in the green today after a troubling week of variant concerns. The same can be said for airline stocks, as names such as&nbsp;<b>Delta</b>&nbsp;(NYSE:<b><u>DAL</u></b>) and&nbsp;<b>Southwest</b>&nbsp;(NYSE:<b><u>LUV</u></b>) have gained some altitude today.</p>\n<p>Of course, it’s too soon to tell what the future will look like. The preliminary results upon which Dr. Fauci commented are exactly that — preliminary. Scientists and medical researchers still have plenty of research to do before they will be able outline a bigger picture. Dr. Fauci was careful to add that while there does not seem to be a “great degree of severity” to the spreading variant, it is still too early for any definitive conclusions to be reached. Omicron is still very much a variant of concern.</p>\n<p>What It Means</p>\n<p>Even if the variant does not end up posing as serious a threat to highly vaccinated countries as has been speculated, the need for vaccines isn’t going to go away. Fear of the variant has spiked&nbsp;demand&nbsp;for vaccinations in the U.S., and many countries are still struggling to get more of their populations partially or fully vaccinated. The industry landscape may not end up looking quite as bleak close to home as some of us have feared. However, that doesn’t mean that the demand for vaccines won’t be increasing throughout the months ahead.</p>\n<p>This news certainly doesn’t mean that a bearish play on vaccine stocks is advisable. Far from it, in fact. Novavax has an&nbsp;important catalyst&nbsp;rapidly approaching as the World Health Organization (WHO) considers granting it emergency use authorization. More than likely, vaccine stocks will be quick to rebound.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaccine Stocks: Why MRNA, BNTX, NVAX, PFE Stocks Are Stumbling Today</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaccine Stocks: Why MRNA, BNTX, NVAX, PFE Stocks Are Stumbling Today\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-07 09:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/12/vaccine-stocks-why-mrna-bntx-nvax-pfe-stocks-are-stumbling-today/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Good news for public health can sometimes mean bad news for vaccine stocks. Today reminded us exactly why. After more than a week of ominous reports on the omicron virus and mounting speculation about...</p>\n\n<a href=\"https://investorplace.com/2021/12/vaccine-stocks-why-mrna-bntx-nvax-pfe-stocks-are-stumbling-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","MRNA":"Moderna, Inc.","BNTX":"BioNTech SE","PFE":"辉瑞"},"source_url":"https://investorplace.com/2021/12/vaccine-stocks-why-mrna-bntx-nvax-pfe-stocks-are-stumbling-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1165217690","content_text":"Good news for public health can sometimes mean bad news for vaccine stocks. Today reminded us exactly why. After more than a week of ominous reports on the omicron virus and mounting speculation about its severity, yesterday brought some welcome news. Dr. Anthony Fauci, White House chief medical officer and a trusted expert on the virus, stated yesterday that some clear preliminary data was finally starting to emerge on the severity of the new variant and that so far, the results looked“encouraging.”\nWhat’s Happening With Vaccine Stocks\nSince news of the new variant first began dominating media airwaves, vaccine producers have been scrambling to be the first to address the new Covid-19 strain that threatened to undo the work that sent their stocks up earlier this year. Today has seen all the prominent names among vaccine stocks plunge across the board. While this isn’t strictly due to Dr. Fauci’s comments, it’s possible that the demand for new vaccine innovations and treatments may not be as great as we feared only a few days ago.\nBioNTech (NASDAQ:BNTX) has suffered the worst declines of the day among vaccine stocks, with shares down almost 19% as of this writing. Next in line is Moderna(NASDAQ:MRNA), which has fallen more than 13%. Then, Novavax’s(NASDAQ:NVAX)declines come in just shy of 12%. Rounding out the pack is Pfizer(NYSE:PFE), which is in the red by just over 5% as trading winds to a close today.\nWhy It Matters\nThe clearest indication we should take from today’s events is that market mentality is shifting. This is evidenced by the performances we’ve seen not just from vaccine stocks but from other sectors that were differently affected by the spreading variant news. As InvestorPlace’s Shrey Dua reports, cruise ship stocks such as Royal Caribbean(NYSE:RCL) and Carnival(NYSE:CCL) are back in the green today after a troubling week of variant concerns. The same can be said for airline stocks, as names such as Delta (NYSE:DAL) and Southwest (NYSE:LUV) have gained some altitude today.\nOf course, it’s too soon to tell what the future will look like. The preliminary results upon which Dr. Fauci commented are exactly that — preliminary. Scientists and medical researchers still have plenty of research to do before they will be able outline a bigger picture. Dr. Fauci was careful to add that while there does not seem to be a “great degree of severity” to the spreading variant, it is still too early for any definitive conclusions to be reached. Omicron is still very much a variant of concern.\nWhat It Means\nEven if the variant does not end up posing as serious a threat to highly vaccinated countries as has been speculated, the need for vaccines isn’t going to go away. Fear of the variant has spiked demand for vaccinations in the U.S., and many countries are still struggling to get more of their populations partially or fully vaccinated. The industry landscape may not end up looking quite as bleak close to home as some of us have feared. However, that doesn’t mean that the demand for vaccines won’t be increasing throughout the months ahead.\nThis news certainly doesn’t mean that a bearish play on vaccine stocks is advisable. Far from it, in fact. Novavax has an important catalyst rapidly approaching as the World Health Organization (WHO) considers granting it emergency use authorization. More than likely, vaccine stocks will be quick to rebound.","news_type":1,"symbols_score_info":{"BNTX":0.9,"MRNA":0.9,"NVAX":0.9,"PFE":0.9}},"isVote":1,"tweetType":1,"viewCount":1938,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603626872,"gmtCreate":1638407150732,"gmtModify":1638407150803,"author":{"id":"4098678914535810","authorId":"4098678914535810","name":"Autnet","avatar":"https://static.tigerbbs.com/bda7244c323527b36de06db53911ab08","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098678914535810","authorIdStr":"4098678914535810"},"themes":[],"htmlText":"Heal the world…. Make it a better place😊","listText":"Heal the world…. Make it a better place😊","text":"Heal the world…. Make it a better place😊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/603626872","repostId":"1196358645","repostType":4,"isVote":1,"tweetType":1,"viewCount":2489,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604441479,"gmtCreate":1639441708814,"gmtModify":1639441708882,"author":{"id":"4098678914535810","authorId":"4098678914535810","name":"Autnet","avatar":"https://static.tigerbbs.com/bda7244c323527b36de06db53911ab08","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098678914535810","authorIdStr":"4098678914535810"},"themes":[],"htmlText":"Heal the world… make it a better place…. For you and for me☘️☘️☘️ Merry Christmas to All🎄🎄🎄","listText":"Heal the world… make it a better place…. For you and for me☘️☘️☘️ Merry Christmas to All🎄🎄🎄","text":"Heal the world… make it a better place…. For you and for me☘️☘️☘️ Merry Christmas to All🎄🎄🎄","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/604441479","repostId":"1133455327","repostType":4,"repost":{"id":"1133455327","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639406792,"share":"https://www.laohu8.com/m/news/1133455327?lang=&edition=full","pubTime":"2021-12-13 22:46","market":"us","language":"en","title":"Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1133455327","media":"Tiger Newspress","summary":"Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping ove","content":"<p>Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%.</p>\n<p><img src=\"https://static.tigerbbs.com/67d7d63c674aea0dff679d8317fc7728\" tg-width=\"537\" tg-height=\"199\" referrerpolicy=\"no-referrer\">A new Israeli study&nbsp;showed that a booster shot from their Covid-19 vaccine provided strong protection against severe illness from the omicron variant.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-13 22:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%.</p>\n<p><img src=\"https://static.tigerbbs.com/67d7d63c674aea0dff679d8317fc7728\" tg-width=\"537\" tg-height=\"199\" referrerpolicy=\"no-referrer\">A new Israeli study&nbsp;showed that a booster shot from their Covid-19 vaccine provided strong protection against severe illness from the omicron variant.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","BNTX":"BioNTech SE"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1133455327","content_text":"Vaccine Stocks rebounded in morning trading, with BioNTech SE rising over 5% and Novavax jumping over 4%.\nA new Israeli study showed that a booster shot from their Covid-19 vaccine provided strong protection against severe illness from the omicron variant.","news_type":1,"symbols_score_info":{"BNTX":0.9,"NVAX":0.9}},"isVote":1,"tweetType":1,"viewCount":1315,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608007502,"gmtCreate":1638578434765,"gmtModify":1638578434765,"author":{"id":"4098678914535810","authorId":"4098678914535810","name":"Autnet","avatar":"https://static.tigerbbs.com/bda7244c323527b36de06db53911ab08","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098678914535810","authorIdStr":"4098678914535810"},"themes":[],"htmlText":"Heal the world…make it a better place☘️☘️☘️","listText":"Heal the world…make it a better place☘️☘️☘️","text":"Heal the world…make it a better place☘️☘️☘️","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/608007502","repostId":"1177965649","repostType":2,"isVote":1,"tweetType":1,"viewCount":2620,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875628055,"gmtCreate":1637646197373,"gmtModify":1637646200152,"author":{"id":"4098678914535810","authorId":"4098678914535810","name":"Autnet","avatar":"https://static.tigerbbs.com/bda7244c323527b36de06db53911ab08","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098678914535810","authorIdStr":"4098678914535810"},"themes":[],"htmlText":"Hmmm… both","listText":"Hmmm… both","text":"Hmmm… both","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/875628055","repostId":"1107351089","repostType":4,"isVote":1,"tweetType":1,"viewCount":1834,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602030171,"gmtCreate":1638937159242,"gmtModify":1638937159242,"author":{"id":"4098678914535810","authorId":"4098678914535810","name":"Autnet","avatar":"https://static.tigerbbs.com/bda7244c323527b36de06db53911ab08","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098678914535810","authorIdStr":"4098678914535810"},"themes":[],"htmlText":"Thanks for the advice. Will seriously consider if selling is imminent… or later?","listText":"Thanks for the advice. Will seriously consider if selling is imminent… or later?","text":"Thanks for the advice. Will seriously consider if selling is imminent… or later?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602030171","repostId":"1105817084","repostType":4,"repost":{"id":"1105817084","kind":"news","pubTimestamp":1638933976,"share":"https://www.laohu8.com/m/news/1105817084?lang=&edition=full","pubTime":"2021-12-08 11:26","market":"us","language":"en","title":"Apple Stock: What Happens When The Cash Runs Out?","url":"https://stock-news.laohu8.com/highlight/detail?id=1105817084","media":"TheStreet","summary":"Apple is about to run out of cash. This statement may sound lucrac is to most Apple stock  investors, since the Cupertino company has been a cash-generating machine in the past many years. But even the management team knows this to be true.Today, the Apple Maven talks about what has been happening to the iPhone maker’s once giant pile of cash, and what the declining balances may mean for shareholders.To be fair, “running out of cash” in this context does not mean that Apple’s checking accounts a","content":"<p>Apple is about to run out of cash. This statement may sound lucrac&nbsp;is to most Apple stock&nbsp;(<b>AAPL</b>)&nbsp;investors, since the Cupertino company has been a cash-generating machine in the past many years. But even the management team&nbsp;knows&nbsp;this to be true.</p>\n<p>Today, the Apple Maven talks about what has been happening to the iPhone maker’s once giant pile of cash, and what the declining balances may mean for shareholders.</p>\n<p><b>Apple heading to net cash neutral</b></p>\n<p>To be fair, “running out of cash” in this context does not mean that Apple’s checking accounts at the bank will dry out. It simply means that the company’s debt balances will roughly offset its cash position — i.e. Apple will become net cash neutral.</p>\n<p>The chart below shows the evolution of Apple’s gross cash (blue bars) and net cash (orange bars) balances since 2011. Ten years ago was when then-CEO Steve Jobs stepped down and turned the control of the company over to then-COO Tim Cook.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/435c5199979bc64d49899feed29d15fb\" tg-width=\"1200\" tg-height=\"723\" width=\"100%\" height=\"auto\"><span>Figure 2:Apple's cash position, fiscal 2012-2021.data from Seeking Alpha</span></p>\n<p>Starting in 2012, Apple began issuing debt for the first time in its history. By 2017, the company boasted the largest gross and net-of-debt cash balances that it had ever seen in its books. But since then, both numbers have been dwindling. This year’s $72 billion in net cash is less than half the amount of about four years ago.</p>\n<p><b>What happens when cash runs out?</b></p>\n<p>The chart below shows that, prior to Tim Cook as CEO, Apple was very timid at deploying its cash reserves. While capex and dividend payments increased quickly (large M&amp;A has never been a thing for Apple), buybacks skyrocketed. Apple has spent more than three times as much in share repurchases since 2018 than it did in capex and dividends combined.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/e0ecee1dedf8551b616732dc7180c574\" tg-width=\"1200\" tg-height=\"694\" width=\"100%\" height=\"auto\"><span>Figure 3:Apple's cash deployment by major category.data from Seeking Alpha</span></p>\n<p>As Apple’s cash balance continues to dip, it is reasonable to expect the pace of share retirement to decline as well. This is true not only because of a leaner balance sheet, but because AAPL stock trades at a much richer price today — thus, it costs Apple more to buy back each share of its own equity.</p>\n<p>Why is this relevant for investors? Over the past decade, Apple’s shares outstanding have declined by 10 billion units to 16.7 billion. Share count is the denominator in EPS (earnings per share) and EPS is the denominator in price-to-earnings. Therefore, buybacks alone have probably been responsible for a good chunk of Apple stock’s climb in the past several years.</p>\n<p>At the current stock price of $165 apiece, Apple can afford to retire around 435 million more shares with its current net cash balance, or barely 3% of the float. After that point, the Cupertino company might need to scale back on repurchases or borrow in order to keep buying its stock.</p>\n<p><b>Should investors worry?</b></p>\n<p>I think that Apple stock could suffer, at least from deteriorated investor sentiment, if or once it begins to slow down the pace of its share buyback efforts. However, I also believe that this is only one aspect of the investment thesis that people should consider.</p>\n<p>I remain optimistic about Apple stock from a business fundamentals perspective. The Cupertino company seems to have found the sweet spot in demand for its products and services, which I believe bodes very well for AAPL in the foreseeable future.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple Stock: What Happens When The Cash Runs Out?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple Stock: What Happens When The Cash Runs Out?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-08 11:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/apple/stock/apple-stock-what-happens-when-the-cash-runs-out><strong>TheStreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Apple is about to run out of cash. This statement may sound lucrac is to most Apple stock (AAPL) investors, since the Cupertino company has been a cash-generating machine in the past many years. But ...</p>\n\n<a href=\"https://www.thestreet.com/apple/stock/apple-stock-what-happens-when-the-cash-runs-out\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.thestreet.com/apple/stock/apple-stock-what-happens-when-the-cash-runs-out","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1105817084","content_text":"Apple is about to run out of cash. This statement may sound lucrac is to most Apple stock (AAPL) investors, since the Cupertino company has been a cash-generating machine in the past many years. But even the management team knows this to be true.\nToday, the Apple Maven talks about what has been happening to the iPhone maker’s once giant pile of cash, and what the declining balances may mean for shareholders.\nApple heading to net cash neutral\nTo be fair, “running out of cash” in this context does not mean that Apple’s checking accounts at the bank will dry out. It simply means that the company’s debt balances will roughly offset its cash position — i.e. Apple will become net cash neutral.\nThe chart below shows the evolution of Apple’s gross cash (blue bars) and net cash (orange bars) balances since 2011. Ten years ago was when then-CEO Steve Jobs stepped down and turned the control of the company over to then-COO Tim Cook.\nFigure 2:Apple's cash position, fiscal 2012-2021.data from Seeking Alpha\nStarting in 2012, Apple began issuing debt for the first time in its history. By 2017, the company boasted the largest gross and net-of-debt cash balances that it had ever seen in its books. But since then, both numbers have been dwindling. This year’s $72 billion in net cash is less than half the amount of about four years ago.\nWhat happens when cash runs out?\nThe chart below shows that, prior to Tim Cook as CEO, Apple was very timid at deploying its cash reserves. While capex and dividend payments increased quickly (large M&A has never been a thing for Apple), buybacks skyrocketed. Apple has spent more than three times as much in share repurchases since 2018 than it did in capex and dividends combined.\nFigure 3:Apple's cash deployment by major category.data from Seeking Alpha\nAs Apple’s cash balance continues to dip, it is reasonable to expect the pace of share retirement to decline as well. This is true not only because of a leaner balance sheet, but because AAPL stock trades at a much richer price today — thus, it costs Apple more to buy back each share of its own equity.\nWhy is this relevant for investors? Over the past decade, Apple’s shares outstanding have declined by 10 billion units to 16.7 billion. Share count is the denominator in EPS (earnings per share) and EPS is the denominator in price-to-earnings. Therefore, buybacks alone have probably been responsible for a good chunk of Apple stock’s climb in the past several years.\nAt the current stock price of $165 apiece, Apple can afford to retire around 435 million more shares with its current net cash balance, or barely 3% of the float. After that point, the Cupertino company might need to scale back on repurchases or borrow in order to keep buying its stock.\nShould investors worry?\nI think that Apple stock could suffer, at least from deteriorated investor sentiment, if or once it begins to slow down the pace of its share buyback efforts. However, I also believe that this is only one aspect of the investment thesis that people should consider.\nI remain optimistic about Apple stock from a business fundamentals perspective. The Cupertino company seems to have found the sweet spot in demand for its products and services, which I believe bodes very well for AAPL in the foreseeable future.","news_type":1,"symbols_score_info":{"AAPL":0.9}},"isVote":1,"tweetType":1,"viewCount":1737,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609779087,"gmtCreate":1638332392917,"gmtModify":1638332392917,"author":{"id":"4098678914535810","authorId":"4098678914535810","name":"Autnet","avatar":"https://static.tigerbbs.com/bda7244c323527b36de06db53911ab08","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098678914535810","authorIdStr":"4098678914535810"},"themes":[],"htmlText":"Let’s pray that vaccines available still continue to work on all variants…","listText":"Let’s pray that vaccines available still continue to work on all variants…","text":"Let’s pray that vaccines available still continue to work on all variants…","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/609779087","repostId":"1134775339","repostType":2,"repost":{"id":"1134775339","kind":"news","pubTimestamp":1638325598,"share":"https://www.laohu8.com/m/news/1134775339?lang=&edition=full","pubTime":"2021-12-01 10:26","market":"us","language":"en","title":"Is a Stock Market Correction Coming? Here’s a Big Red Flag","url":"https://stock-news.laohu8.com/highlight/detail?id=1134775339","media":"Barrons","summary":"To say that the Omicron variant is shaking the market would be an understatement. But add that stock","content":"<p>To say that the Omicron variant is shaking the market would be an understatement. But add that stocks are more expensive than they’ve ever been—and a true correction now wouldn’t surprise anybody.</p>\n<p>The S&amp;P 500 has fallen almost 3% from its all-time high hit in late November, just before scientists in South Africa reported the new Covid-19 strain. On Friday, the market had its worst day of the year. Tuesday was more ugliness—producers of vaccines and treatments predicted their remedies probably wouldn’t be as effective against Omicron as other variants.</p>\n<p>But that true correction—a 10% drop—has been elusive, even during all these months of the pandemic. And that itself is a bit astonishing, since corrections are often a normal part of a larger bull market.</p>\n<p>One indicator, though, forecasts a correction—like a dark cloud usually brings rain. The total U.S. equity market capitalization is about 215% of U.S. gross domestic product—the highest level ever, according to Global Financial Data.</p>\n<p>Such a high number isn’t good. It’s bad, often a sign that a correction is just around the corner</p>\n<p>In 1929, market cap to GDP hit an all-time high of about 100%, just before the famous stock market crash late that year. In 2000, another high at about 150%, just before a bear market—a drop of at least 20%—began. In 2008, a multiyear high, just ahead of the financial crisis.</p>\n<p>The upshot: Maybe a correction; then again, maybe not. It’s all in the hands of investors.</p>\n<p>To be sure, stock valuations aren’t known to be the best timing tool for investors deciding if they should do more buying or selling. Valuations can stay high for a long time.</p>\n<p>For most of the pandemic era, in fact, the market has been valued at its highest level relative to GDP ever. But high valuations do indicate that when—and if—the economic outlook really does deteriorate, stocks can fall really hard.</p>\n<p>“There is certainly the potential for additional market drops and heightened volatility in coming weeks as a result of this variant, especially given all the uncertainty surrounding it,” wrote Kristina Hooper, chief global market strategist at Invesco. “There is room for a decent correction.”</p>\n<p>What the market needs now is a little hope—that vaccines will be effective against the new variant. Otherwise, get ready for a correction.</p>","source":"market_watch","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is a Stock Market Correction Coming? Here’s a Big Red Flag</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs a Stock Market Correction Coming? Here’s a Big Red Flag\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-01 10:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/articles/stock-market-correction-51638305804?mod=newsviewer_click_seemore><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>To say that the Omicron variant is shaking the market would be an understatement. But add that stocks are more expensive than they’ve ever been—and a true correction now wouldn’t surprise anybody.\nThe...</p>\n\n<a href=\"https://www.marketwatch.com/articles/stock-market-correction-51638305804?mod=newsviewer_click_seemore\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index"},"source_url":"https://www.marketwatch.com/articles/stock-market-correction-51638305804?mod=newsviewer_click_seemore","is_english":true,"share_image_url":"https://static.laohu8.com/599a65733b8245fcf7868668ef9ad712","article_id":"1134775339","content_text":"To say that the Omicron variant is shaking the market would be an understatement. But add that stocks are more expensive than they’ve ever been—and a true correction now wouldn’t surprise anybody.\nThe S&P 500 has fallen almost 3% from its all-time high hit in late November, just before scientists in South Africa reported the new Covid-19 strain. On Friday, the market had its worst day of the year. Tuesday was more ugliness—producers of vaccines and treatments predicted their remedies probably wouldn’t be as effective against Omicron as other variants.\nBut that true correction—a 10% drop—has been elusive, even during all these months of the pandemic. And that itself is a bit astonishing, since corrections are often a normal part of a larger bull market.\nOne indicator, though, forecasts a correction—like a dark cloud usually brings rain. The total U.S. equity market capitalization is about 215% of U.S. gross domestic product—the highest level ever, according to Global Financial Data.\nSuch a high number isn’t good. It’s bad, often a sign that a correction is just around the corner\nIn 1929, market cap to GDP hit an all-time high of about 100%, just before the famous stock market crash late that year. In 2000, another high at about 150%, just before a bear market—a drop of at least 20%—began. In 2008, a multiyear high, just ahead of the financial crisis.\nThe upshot: Maybe a correction; then again, maybe not. It’s all in the hands of investors.\nTo be sure, stock valuations aren’t known to be the best timing tool for investors deciding if they should do more buying or selling. Valuations can stay high for a long time.\nFor most of the pandemic era, in fact, the market has been valued at its highest level relative to GDP ever. But high valuations do indicate that when—and if—the economic outlook really does deteriorate, stocks can fall really hard.\n“There is certainly the potential for additional market drops and heightened volatility in coming weeks as a result of this variant, especially given all the uncertainty surrounding it,” wrote Kristina Hooper, chief global market strategist at Invesco. “There is room for a decent correction.”\nWhat the market needs now is a little hope—that vaccines will be effective against the new variant. Otherwise, get ready for a correction.","news_type":1,"symbols_score_info":{".SPX":0.9}},"isVote":1,"tweetType":1,"viewCount":2214,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":874183713,"gmtCreate":1637743910331,"gmtModify":1637743910331,"author":{"id":"4098678914535810","authorId":"4098678914535810","name":"Autnet","avatar":"https://static.tigerbbs.com/bda7244c323527b36de06db53911ab08","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098678914535810","authorIdStr":"4098678914535810"},"themes":[],"htmlText":"Bought some for long terms gain… 😄","listText":"Bought some for long terms gain… 😄","text":"Bought some for long terms gain… 😄","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/874183713","repostId":"2185804343","repostType":2,"isVote":1,"tweetType":1,"viewCount":2167,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":844218737,"gmtCreate":1636429829281,"gmtModify":1636430056505,"author":{"id":"4098678914535810","authorId":"4098678914535810","name":"Autnet","avatar":"https://static.tigerbbs.com/bda7244c323527b36de06db53911ab08","crmLevel":11,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4098678914535810","authorIdStr":"4098678914535810"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/LCID\">$Lucid Group Inc(LCID)$</a>Up up all the way 😄","listText":"<a href=\"https://laohu8.com/S/LCID\">$Lucid Group Inc(LCID)$</a>Up up all the way 😄","text":"$Lucid Group Inc(LCID)$Up up all the way 😄","images":[{"img":"https://static.tigerbbs.com/6d051f1bdcdd23ae132420f6f7bf3c8d","width":"1125","height":"2710"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/844218737","isVote":1,"tweetType":1,"viewCount":2612,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"CN","totalScore":0}],"lives":[]}